ctbelize.com – Impact Stories & Daily Wraps

In a significant boost for Indian healthcare, GST 2.0, effective September 22, 2025, brings major tax relief. Thirty-three life-saving drugs are GST-exempt, while critical cancer and rare disease medications are zero-rated. Most other medicines will see a reduced 5% GST. Medical devices and health insurance policies also benefit from lower or no GST, making healthcare more affordable and accessible nationwide.